MK-677 Ibutamoren Capsules

MK-677 Capsules, known as Ibutamoren, are recognized for their potential ability to stimulate growth hormone secretion, supporting muscle growth, bone density, and metabolic functions. Scientific studies indicate that MK-677 potentially enhances levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), possibly contributing to improved body composition and potentially benefiting conditions such as growth hormone deficiency, muscle wasting, and osteoporosis.

MK-677 Ibutamoren Capsules Product Details

• MK 677 Ibutamoren Capsules are offered as 20mg/60ct/1.2g
• CAS Number is stated as 159634-47-6
• Molar Mass is 528.67 g·mol−1
• It has a Chemical Formula of C27H36N4O5S
• IUPAC Name is 2-amino-2-methyl-N-[1-(1-methylsulfonylspiro[2H-indole-3,4′-piperidine]-1′-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide
• Also known by Synonyms as MK-677; MK-0677; L-163,191; Oratrope
• Available in 20 mg/30 ct/600 mg and 20 mg/60 ct/1.2 g

What is MK-677 Ibutamoren? 

MK 677 / Ibutamoren is an orally active growth hormone secretagogue. Studies have found that it releases GH from pituitary cells. In a trial involving children test subjects with GH deficiency (GHD), MK 677 was shown to elicit greater GH responses than standard GH secretagogues. [R]

Ibutamoren also increases insulin-like growth factor 1 (IGF-1) levels. Animal studies have demonstrated that repeat administrations of MK 677 increase and maintain elevated IGF-1 levels. Various clinical trials have also shown that MK 677 increases IGF-1 levels. [R][R]

MK 677 has also been shown to increase IGF binding protein 3 (IGFBP-3) concentrations in healthy older test subjects and GH-deficient adult test subjects. Aside from that, clinical studies have established that this GH secretagogue improves body composition and metabolism in older test subjects. [R]

Packaged in an air-sealed mylar bag. Keep contents sealed and stored in a cool dry place.  Items are shipped in a plain envelope or bubble mailer within 24-48 hours (or the next business day).

We also offer MK-677 Ibutamoren in Liquid Form if you are interested in those instead.

BehemothLabz sells MK 677 for laboratory research use only.

Why Use Capsules? 

Capsules offer several advantages over other forms of delivery, such as liquids and injections. They provide convenience by being easy to store, transport, and administer without the need for measuring devices or precise handling like liquids or injections. Capsules ensure accurate dosage with each unit, maintaining consistency and avoiding dosing errors common with liquids. Their stability ensures research compounds retain potency until their expiry, unlike liquids which may degrade over time. Capsules also mask unpleasant tastes and odors. Additionally, their sealed nature reduces the risk of contamination and enhances test subjects’ compliance due to their ease of swallowing and integration into daily routines.

Potential Applications of MK-677

MK677 and Sleep Quality

Clinical studies have shown that MK-677, also known as Ibutamoren, may potentially improve sleep quality. In younger adult test subjects, it resulted in a 20% increase in REM sleep, while older adult test subjects experienced a 50% increase in REM sleep compared to a placebo. Additionally, young test subjects saw a 50% increase in stage IV sleep duration with MK-677 treatment, highlighting its importance for potential restorative sleep and overall health. [R]

The potential benefits of MK-677 extend beyond just increasing the time spent in various sleep stages. The frequency of deviations from normal sleep patterns drastically decreased with high-dose MK-677 treatment, dropping from 42% under placebo conditions to just 8%. This reduction in sleep disturbances suggests that MK-677 not only potentially enhances the quality of sleep but also possibly promotes a more consistent and stable sleep pattern. Overall, these findings indicate that MK-677 has significant potential as a treatment to improve sleep quality, particularly in potentially enhancing REM and stage IV sleep and reducing sleep abnormalities. [R]

BehemothLabz sells MK 677 for laboratory research use only.

MK677 and Body Composition

In a 1998 study with 24 obese male test subjects, a two-month course of MK-677 potentially led to increased lean muscle mass, boosted energy expenditure, and higher levels of growth hormone (GH). Researchers noted that these shifts in body composition and energy use were anabolic, suggesting a possible enhanced muscle growth and metabolic activity. [R]

In another trial, MK-677 treatment potentially reduced abdominal fat mass in obese male test subjects and positively influenced lipoprotein metabolism. Additionally, this GH secretagogue potentially improved insulin sensitivity without affecting blood glucose levels or systolic blood pressure, making it a potentially safe option for metabolic enhancement. [R]

A third placebo-controlled trial reinforced these findings. In a placebo-controlled trial, those receiving MK-677 experienced a rise in fat-free mass, while the placebo group saw a decline. Additionally, the MK-677 group had an average weight gain of 2.7 kg and a decrease in LDL cholesterol. These findings underscore MK-677’s potential to increase lean body mass, reduce fat, and enhance overall metabolic health. [R]

MK677 and Bone Density

In a study involving postmenopausal women test subjects with osteoporosis, those administered MK-677 potentially exhibited a significant rise in bone mineral density at the femoral neck, a key area for preventing fractures. This finding suggests that MK-677 might be beneficial in strengthening bones and lowering fracture risk in participants with osteoporosis. [R]

Another study discovered that daily MK-677 administration elevated bone turnover markers in both healthy older test subjects and those with functional impairments. The rise in biochemical indicators of bone resorption and formation indicates that MK-677 may promote bone remodeling, which is crucial for potentially maintaining bone health. [R]

Similarly, research involving healthy obese young men test subjects aged 19 to 49 demonstrated that a two-week treatment with Ibutamoren potentially boosted markers of bone resorption and formation. These elevated markers remained consistent throughout the eight-week study period, underscoring MK-677’s potential to potentially improve bone health across various demographics. [R]

MK677 and Sarcopenia

Sarcopenia, the age-related decline in muscle mass and strength, contributes to frailty and increased mortality rates in older adults. Research has shown mortality rates as high as 29% in elderly affected by this condition. [R][R]

In trials, MK-677 has shown potential in addressing key factors linked to sarcopenia development. These factors involve potentially reversing the decrease in growth hormone secretion linked to aging, preserving fat-free mass (FFM), and managing problems associated with low appetite or inadequate food intake often seen in aging participants. [R]

Moreover, a study concentrated on frail elderly women test subjects examined the safety and effectiveness of MK-677 for potentially treating sarcopenia. Outcomes showed that test subjects who received Ibutamoren saw a notable rise in lean body mass after six months of therapy. These results highlight MK-677’s potential to reduce muscle decline and improve muscle mass in frail older adult test subjects grappling with sarcopenia. [R]

MK677 and Muscle Wasting

Muscle wasting, characterized by significant loss of muscle mass, which can reach up to 40% in severe cases, is frequently associated with reduced muscle strength. Causes of muscle wasting include malnutrition, aging, genetic factors, and sedentary lifestyles. [R][R]

In clinical research, MK-677 has demonstrated potentially encouraging outcomes in mitigating diet-induced protein breakdown in a double-blind, placebo-controlled study involving healthy volunteers aged 24 to 39. If these benefits translate to test subjects experiencing catabolism due to illnesses, MK-677 may hold promise as a potential therapeutic option for managing various catabolic conditions. [R]

Furthermore, a phase IIB study involving elderly test subjects recovering from hip fractures demonstrated that Ibutamoren treatment potentially increased muscle strength and gait speed. This GH secretagogue also reduced the incidence of falls among test subjects. These findings highlight MK-677’s potential in combating muscle wasting and improving functional outcomes in elderly test subjects with compromised muscle health. [R]

MK677 and Growth Hormone Deficiency

MK-677, also called Ibutamoren, offers potential advantages for volunteers experiencing growth hormone deficiency (GHD). GHD is characterized by inadequate levels of growth hormone, resulting in symptoms such as reduced sexual function, sensitivity to temperature fluctuations, and increased fat accumulation in the abdominal area. [R]

Research trials have revealed that MK-677 may trigger more robust growth hormone responses compared to conventional GH secretagogues in children test subjects diagnosed with GHD. This effect was particularly notable in test subjects who initially showed higher responses to traditional GH stimulants, underscoring MK-677’s potential in augmenting growth hormone production. [R]

In similar studies with male test subjects diagnosed with GH deficiency, MK-677 treatment has demonstrated a potential ability to elevate growth hormone levels, particularly in volunteers with milder deficiency at the study’s outset. These findings suggest that administering MK-677 might be a viable treatment option for growth hormone deficiency, especially in pediatric cases. [R]

How do MK-677 Ibutamoren Capsules Work? 

MK-677, also known as Ibutamoren, functions by mimicking the action of ghrelin, a hormone that potentially stimulates growth hormone release. It binds to ghrelin receptors in the brain, specifically the growth hormone secretagogue receptor (GHSR). Activation of these receptors prompts the pituitary gland to potentially increase the secretion of growth hormone (GH). Additionally, MK-677 influences the release of insulin-like growth factor 1 (IGF-1), which plays a crucial role in muscle growth and repair, bone density, and overall metabolic health. By stimulating both GH and IGF-1, MK-677 promotes anabolic processes in the body, contributing to potentially increased muscle mass, improved bone density, and enhanced recovery and repair mechanisms.

Safety and Side Effects

Commonly noted side effects include heightened appetite, slight fluid retention (edema), and muscle discomfort. There are more serious side effects to consider. MK-677 may lead to heightened insulin resistance, a notable concern for participants with diabetes or those predisposed to the condition. Some test subjects have reported higher fasting blood glucose and elevated HbA1c levels. Additionally, MK-677 may increase cortisol levels, which, if prolonged, may result in various negative effects on the body.

Another potential concern is the impact on sleep patterns. While some test subjects notice better sleep quality, others might encounter disrupted sleep or vivid dreams. Additionally, since MK-677 boosts growth hormone levels, there is a theoretical risk of promoting the growth of existing tumors, though there is no solid evidence to support this in human subjects.

Frequently Asked Questions 

How MK677 works?  

MK-677, also known as Ibutamoren, functions as a growth hormone secretagogue, potentially encouraging the body to produce more growth hormone (GH). It mimics ghrelin, a hormone that binds to receptors in the brain known as growth hormone secretagogue receptors (GHSR). When these receptors are activated, the pituitary gland is stimulated to release more GH. This rise in GH levels causes the liver to produce insulin-like growth factor 1 (IGF-1), which is essential for muscle growth, bone density, and other anabolic processes. The combined increase in GH and IGF-1 potentially promotes muscle growth, improves bone density, supports tissue recovery and repair, and may enhance sleep quality and metabolic health. Due to this mechanism, MK-677 shows potential in treating growth hormone deficiency, muscle wasting, and sarcopenia.

Can MK677 cause cancer? 

The potential association between MK-677, also known as Ibutamoren, and cancer development is a subject under active investigation. Reported cases, such as adenocarcinoma of the tongue and colon cancer in clinical trial participants using MK-677, highlight concerns but do not establish a definitive causal link. These instances are closely monitored within clinical trials to assess any potential risks associated with MK-677 use. Participants experiencing adverse events, including cancer diagnoses, are typically withdrawn from studies for thorough evaluation and monitoring. While these cases underscore the need for continued research into MK-677’s safety profile, current evidence does not conclusively demonstrate that MK-677 directly causes cancer in human test subjects. Ongoing studies aim to provide more clarity on the potential risks and benefits associated with MK-677 use, particularly regarding its long-term effects on health and cancer risk.

Is MK677 a SARM? 

MK-677, also known as Ibutamoren, is not a Selective Androgen Receptor Modulator (SARM). While both MK-677 and SARMs are often grouped together in discussions about performance-enhancing compounds, they have distinct mechanisms of action and effects.

SARMs specifically target androgen receptors in bone and muscle tissues, potentially aimed to promote muscle growth and enhance bone density selectively. In contrast, MK-677 functions as a growth hormone secretagogue, mimicking the action of ghrelin to potentially stimulate the secretion of growth hormone (GH) from the pituitary gland. This increase in GH levels leads to higher levels of insulin-like growth factor 1 (IGF-1), which supports muscle growth, bone density, and overall anabolic processes.

Therefore, while both MK-677 and SARMs may have potential applications in enhancing physical performance and muscle growth, they achieve these effects through different biological mechanisms. MK-677’s classification as a growth hormone secretagogue distinguishes it from SARMs in terms of its mechanism of action and intended use.

Why Buy MK-677 Capsules from BehemothLabz?

BehemothLabz is the best place to purchase MK-677 Capsules.

We have been around since 2014, supplying the highest-quality research compounds money can buy. Our products come with a 100% satisfaction guarantee, free and fast shipping, and a money-back guarantee on MK-677 Capsules.

Summary

MK-677 Capsules, also referred to as Ibutamoren, are noted for their potential to trigger growth hormone secretion, promoting muscle growth, bone density, and metabolic functions. Research indicates it potentially increases GH and insulin-like growth factor 1 (IGF-1) levels, improves body composition, and potentially helps conditions such as growth hormone deficiency, muscle wasting, and osteoporosis. Despite offering ease and stability for research applications, volunteers should be cautious of potential side effects such as increased appetite, fluid retention, and effects on insulin sensitivity and cortisol levels. Ongoing research continues to investigate MK-677’s safety profile, particularly regarding long-term use and any potential associations with cancer. Choosing BehemothLabz ensures quality and reliability, supported by extensive experience and a commitment to research integrity.

20mg|30ct|600mg

20mg|60ct|1.2g